BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37872084)

  • 21. Neonatal cholestasis. New approaches to diagnostic evaluation and therapy.
    Shah HA; Spivak W
    Pediatr Clin North Am; 1994 Oct; 41(5):943-66. PubMed ID: 7936782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neonatal cholestasis: the viewpoint of the pediatrician].
    Vegnente A; Iorio R; Guida S
    Pediatr Med Chir; 1993; 15(3):249-55. PubMed ID: 8415172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KIF12 Variants and Disturbed Hepatocyte Polarity in Children with a Phenotypic Spectrum of Cholestatic Liver Disease.
    Stalke A; Sgodda M; Cantz T; Skawran B; Lainka E; Hartleben B; Baumann U; Pfister ED
    J Pediatr; 2022 Jan; 240():284-291.e9. PubMed ID: 34555379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholestasis Familiaris Groenlandica: an epidemiological, clinical and genetic study.
    Nielsen IM; Eiberg H
    Int J Circumpolar Health; 2004; 63 Suppl 2():192-4. PubMed ID: 15736650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathologic Features of Hereditary Cholestatic Diseases.
    Clouston AD
    Surg Pathol Clin; 2018 Jun; 11(2):313-327. PubMed ID: 29751877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnosis of cholestatic disorders].
    Geier A; Gartung C; Dietrich CG; Lammert F; Wasmuth HE; Matern S
    Med Klin (Munich); 2003 Sep; 98(9):499-509. PubMed ID: 14551707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic value of plasma lysosphingolipids levels in a Niemann-Pick disease type C patient with transient neonatal cholestasis.
    Bulut FD; Bozbulut NE; Özalp Ö; Dalgiç B; Mungan NÖ; Koç Uçar H; Biberoğlu G
    J Pediatr Endocrinol Metab; 2022 May; 35(5):681-685. PubMed ID: 35107903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New molecular insights into the mechanisms of cholestasis.
    Wagner M; Zollner G; Trauner M
    J Hepatol; 2009 Sep; 51(3):565-80. PubMed ID: 19595470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholestasis: current issues and plan for the future.
    Haber B; Ferreira CT; Aw M; Bezerra J; Sturm E; Thompson R; D'Agostino D; McKiernan P;
    J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):220-4. PubMed ID: 18664879
    [No Abstract]   [Full Text] [Related]  

  • 30. Alagille syndrome and other hereditary causes of cholestasis.
    Hartley JL; Gissen P; Kelly DA
    Clin Liver Dis; 2013 May; 17(2):279-300. PubMed ID: 23540503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of novel loci for pediatric cholestatic liver disease defined by KIF12, PPM1F, USP53, LSR, and WDR83OS pathogenic variants.
    Maddirevula S; Alhebbi H; Alqahtani A; Algoufi T; Alsaif HS; Ibrahim N; Abdulwahab F; Barr M; Alzaidan H; Almehaideb A; AlSasi O; Alhashem A; Hussaini HA; Wali S; Alkuraya FS
    Genet Med; 2019 May; 21(5):1164-1172. PubMed ID: 30250217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic Yield of an Algorithm for Neonatal and Infantile Cholestasis Integrating Next-Generation Sequencing.
    Nicastro E; Di Giorgio A; Marchetti D; Barboni C; Cereda A; Iascone M; D'Antiga L
    J Pediatr; 2019 Aug; 211():54-62.e4. PubMed ID: 31160058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnosis and therapy of cholestasis].
    Brodanová M
    Cas Lek Cesk; 1993 Apr; 132(8):230-5. PubMed ID: 8306380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chronic cholestatic liver diseases : Differential diagnosis, pathogenesis and current treatment in adults].
    Hohenester S; Beuers U
    Internist (Berl); 2017 Aug; 58(8):805-825. PubMed ID: 28721532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promising traditional Chinese medicine for the treatment of cholestatic liver disease process (cholestasis, hepatitis, liver fibrosis, liver cirrhosis).
    Wei C; Qiu J; Wu Y; Chen Z; Yu Z; Huang Z; Yang K; Hu H; Liu F
    J Ethnopharmacol; 2022 Oct; 297():115550. PubMed ID: 35863612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic contribution of ABCC2 to Dubin-Johnson syndrome and inherited cholestatic disorders.
    Corpechot C; Barbu V; Chazouillères O; Broué P; Girard M; Roquelaure B; Chrétien Y; Dong C; Lascols O; Housset C; Jéru I
    Liver Int; 2020 Jan; 40(1):163-174. PubMed ID: 31544333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Mutational Landscape Of Genetic Cholestatic Diseases In Pakistani Children.
    Cheema HA; Waheed N; Saeed A; Anjum MN; Fayyaz Z; Ijaz S
    J Pak Med Assoc; 2023 Aug; 73(8):1610-1621. PubMed ID: 37697751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cholestasis in adults. 2. Clinical signs and symptomatic treatment].
    Maffei M; Hadengue A
    Rev Med Suisse; 2006 Sep; 2(77):1965-6, 1969-71. PubMed ID: 17007452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The clinico-pathogenetic variants of cholestasis in different liver diseases].
    Ivashkin VT; Ivlev AS; Pliusnin SV; Vasil'ev AP
    Ter Arkh; 1992; 64(2):6-9. PubMed ID: 1509386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent developments in diagnostics and treatment of neonatal cholestasis.
    Feldman AG; Sokol RJ
    Semin Pediatr Surg; 2020 Aug; 29(4):150945. PubMed ID: 32861449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.